First asymmetric total synthesis of (+)-sparteine

Organic Letters

Volumn 4, Issue 15, 2002, Pages 2577-2579

  Smith, Brenton T ^a   Wendt, John A ^a,b   Aubé, Jeffrey ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 NORBORNADIENE; 2,5-NORBORNADIENE; CARDIOVASCULAR AGENT; NORBORNANE DERIVATIVE; SPARTEINE;

ARTICLE; CHEMISTRY; CYCLIZATION; STEREOISOMERISM; SYNTHESIS;

CARDIOVASCULAR AGENTS; CYCLIZATION; NORBORNANES; SPARTEINE; STEREOISOMERISM;

EID: 0001147659     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol026230v     Document Type: Article

References (32)

1. Biological activity: (a) Seeger, R.; Neumann, H. G. Inst. Pharmakol. Toxikol. 1992, 132, 1577-1581. Isolation and structure determination:
2. (b) Karrer, P.; Gränacher, C. Helv. Chim. Acta 1928, 11, 1062-1064.
3. (c) Clemo, G.; Raper, R.; Tenniswood, C. J. Chem. Soc. 1931, 429-437.
4. A SciFinder search for the words "sparteine" and "synthesis" for the period of 1995-2002 yielded 317 references. For reviews of work in this area, see: (a) Beak, P.; Basu, A.; Gallagher, D. J.; Park, Y. S.; Thayumanavan, S. Acc. Chem. Res. 1996, 29, 552-560.
5. (b) Hoppe, D.; Hense, T. Angew. Chem., Int. Ed. Engl. 1997, 36, 2282-2316.
6. Ebner, T.; Eichelbaum, M.; Fischer, P.; Meese, C. O. Arch. Pharm. (Weinheim) 1989, 322, 399-403.
7. Racemic total syntheses of sparteine: (a) Leonard, N. J.; Beyler, R. E. J. Am. Chem. Soc. 1948, 70, 2298-2299.
8. (b) Anet, E. L. F. J.; Hughes, G. K.; Ritchie, E. Aust. J. Sci. Res. 1950, 3A, 635-641.
9. (c) Anet, E.; Hughes, G. K.; Ritchie, E. Nature 1950, 165, 35-36.
10. (d) Van Tamelen, E. E.; Foltz, R. L. J. Am. Chem. Soc. 1960, 82, 2400.
11. (e) Van Tamelen, E. E.; Foltz, R. L. J. Am. Chem. Soc. 1969, 91, 7372-7377.
12. (f) Bohlmann, F.; Müller, H.-J.; Schumann, D. CB 1973, 106, 3026-3034.
13. (g) Binning, F. Arzneim.-Forsch. 1974, 24, 752-753.
14. (h) Oinuma, H.; Dan, S.; Kakisawa, H. J. Chem. Soc., Chem. Commun. 1983, 654-655.
15. (i) Takatsu, N.; Noguchi, M.; Ohmiya, S.; Otomasu, H. Chem. Pharm. Bull. 1987, 35, 4990-4992.
16. (j) Wanner, M. J.; Koomen, G. J. J. Indian Chem. Soc. 1997, 74, 891-895.
17. Early studies related to this synthesis have appeared: Wendt, J. A.; Aubé, J. Tetrahedron Lett. 1996, 37, 1531-1534.
18. Hayashi, T. Acta Chem. Scand. 1996, 50, 259-266.
19. Weissfloch, A.; Azerad, R. Bioorg. Med. Chem. 1994, 2, 493-500.
20. This aldehyde was prepared from butanediol in 90% overall yield by monobenzylation followed by TEMPO oxidation.
21. Viaud, M. C.; Rollin, P. Synthesis 1990, 130-132.
22. Milligan, G. L.; Mossman, C. J.; Aubé, J. J. Am. Chem. Soc. 1995, 117, 10449-10459.
23. 4), but there is no evidence for coordination of the ketone carbonyl in even a very large excess of Lewis acid (> 20 equiv). (2) Even simple acid-promoted reactions such as dimethyl ketal formation of compounds such as 5 have proven difficult.
24. (a) Suginome, H.; Furukawa, K.; Orito, K. J. Chem. Soc., Perkin Trans. 1 1991, 917-921.
25. (b) Suginome, H.; Furukawa, K.; Orito, K. J. Chem. Soc., Chem. Commun. 1987, 1004-1005.
26. (c) Suginome, H.; Kaji, M.; Yamada, S. J. Chem. Soc., Perkin Trans. 1 1988, 321-326.
27. (d) Suginome, H. Kagaku No Ryoiki 1976, 30, 578-591.
28. (a) Johnson, G. P.; Marples, B. A. Tetrahedron Lett. 1985, 26, 4115-4118.
29. (b) Black, D.; Johnstone, L. M. Aust. J. Chem. 1984, 37, 609.
30. (c) Black, D.; Johnstone, L. M. Aust. J. Chem. 1984, 37, 577-585.
31. (d) Albini, A.; Fasani, E.; Frattini, V. J. Chem. Soc., Perkin Trans. 2 1988, 235-240.
32. (e) Bourguet, E.; Baneres, J.-L.; Girard, J.-P.; Parello, J.; Vidal, J.-P.; Lusinchi, X.; Declercq, J.-P. Org. Lett. 2001, 3, 3067-3070.